Nova Minerals Registers Scheme Booklet with ASIC Ahead of U.S. Redomiciliation

NVA
April 22, 2026

Nova Minerals Limited (ASX:NVA) has filed its Scheme Booklet with the Australian Securities and Investments Commission, a key step in the company’s plan to convert its Australian domicile into a U.S. entity. The booklet, which outlines the proposed share‑scheme and warrant‑scheme, will be distributed to shareholders and warrant holders on 28 April 2026.

The filing includes a recent amendment to the Scheme Implementation Deed that changes the warrant conversion ratio from 1:1 to 3:1, a modification required to meet New York Stock Exchange listing rules. Shareholder meetings are scheduled for 29 May 2026, with the redomiciliation expected to take effect on 3 June 2026 if the vote passes. Upon approval, Nova will list its U.S. holding company on the NYSE on 16 June 2026 while maintaining an ASX listing through a continuous disclosure instrument (CDI).

The redomiciliation is driven by the company’s ambition to tap U.S. institutional capital and align its corporate structure with its Alaska‑based Estelle project, which is poised to begin antimony production later this year. Nova recently secured a US$43.4 million award from the U.S. Department of War to develop a domestic antimony supply chain, underscoring the strategic importance of the move. The company’s chief financial officer, Michael Melamed, has resigned, and a search for a U.S.‑based CFO is underway, reflecting the shift in focus toward U.S. operations.

The timing of the scheme booklet registration positions Nova to complete the redomiciliation and NYSE listing within a month of the shareholder vote, while the ASX listing will continue to provide liquidity for Australian investors. The transition marks a pivot from a gold explorer to a critical‑minerals developer, potentially expanding the company’s revenue base and enhancing investor access to a broader capital market.

The announcement signals a strategic realignment that could improve Nova’s access to capital, streamline regulatory compliance, and accelerate the development of its antimony production at Estelle. The move is expected to increase investor liquidity and support the company’s long‑term growth trajectory in the critical‑minerals sector.

The content on EveryTicker is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.